Healthy volunteers help test new liver Drug's safety
NCT ID NCT07110441
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This early-stage study tested a new drug, G1090N, in 52 healthy adults to see how the body processes it and whether it is safe. The goal was to measure drug levels in blood and urine after single and multiple doses. No treatment was given for any disease; the study simply gathered basic safety and drug-handling information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.